Abstract:To investigate the fluorescein angiography (FA) findings and compare the extent of retinal vascularization in retinopathy of prematurity (ROP), recovered after intravitreal ranibizumab (IVR) monotherapy and those regressed spontaneously. Infants with a history of ROP who underwent FA between April 2018 and November 2021 were retrospectively included. The patients were divided into two groups based on whether they had received IVR (IVR group) or had ROP that regressed spontaneously without treatment (untreated group). The differences between the two groups in zone II ROP were also compared, to equalize the subgroups as much as possible in terms of disease severity. FA findings were recorded. The extent of vascularization was measured by the ratio of the distance from the center of the disk to the border of the vascularized zone (DB) and the distance from the center of the disk to the center of the fovea (DF). The width of the persistent avascular retina (PAR) was counted by disc diameters (DD). One hundred and ten eyes of 55 infants were included in the IVR group and 76 eyes of 38 babies in the untreated group. The ratio of abnormal shape of vessels was significantly higher in the IVR group than in the untreated group (50.9% vs. 35.5%; P = 0.038), while the linear choroidal filling pattern, tortuosity of vessels over the posterior pole, dye leakage, anomalous branching of vessels, circumferential vessels, arteriovenous shunt, abnormal capillary bed, and macular abnormalities were similarly. There was a smaller temporal DB/DF ratio (4.48 vs. 4.63; P = 0.003) and greater PAR (2.63 vs. 1.76; P < 0.001) in the IVR group compared to the untreated group. In zone II ROP, the progression of retinal vascularization was significantly larger in the IVR group than that in the untreated group ( P = 0.003), while no statistical differences were observed in FA features, the DB/DF ratio, and PAR between the two subgroups. The residual vascular abnormalities and PAR may be common results of ROP regression. The DB/DF ratio of 4.0 temporally and 3.3 nasally could be used as the preliminary indicators for safe retinal vascularization in the completion of ROP regression.

Unusual Cause of Tarry Stool: What Do You Think?

Incidence of Retinopathy of Prematurity Treatment in Extremely Preterm Infants in China.

Emphasizing the Prevention and Treatment for Retinopathy of Prematurity

Characterization of Errors in Retinopathy of Prematurity Diagnosis by Ophthalmologists-in-Training in Middle-Income Countries

Incidence and Risk Factor Analysis of Retinopathy of Prematurity

Retinopathy of Prematurity: A Global Perspective and Recent Developments.

[Evaluation of Risk Factors for Retinopathy of Prematurity].

Incidence, Risk Factors, and Treatment Outcomes in a Tertiary Care Center

Retinopathy of Prematurity—Targeting Hypoxic and Redox Signaling Pathways

Evaluation of Retinal Vascularization in Retinopathy of Prematurity Regressed after Intravitreal Ranibizumab Monotherapy or Without Treatment Based on Fluorescein Angiography

Prevalence of Unscreened Premature Infants Presenting With Advanced Stages of Retinopathy of Prematurity in South India: An Analysis of 220 Eyes

Retinopathy of prematurity screening: prevalence and risk factors of ophthalmic complications in non-treated preterm infants

An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials

Retinopathy of prematurity in South Africa: an assessment of needs, resources and requirements for screening programmes

Analysis of Non-Retinopathy of Prematurity (rop)–related Fundus Hemorrhage in Preterm Infants in China

Characteristics of Severe Retinopathy of Prematurity Patients in China: A Repeat of the First Epidemic?

Rate and Treatment of Retinopathy of Prematurity in Extremely Low Birth Weight Infants with Gestational Age ≤28 Weeks in Eastern China.

Incidence and Risk Factors of Retinopathy of Prematurity in Two Neonatal Intensive Care Units in North and South China.

Incidence, risk factors, progression, and involution in retinopathy of prematurity at a tertiary care center in South India

[Be Cautious to Treat Retinopathy of Prematurity with Anti-Vascular Endothelial Growth Factor Pharmacotherapy].

Analysis of factors of spontaneous regression of prematurity retinopathy